Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1079 results for "bse healthcare"

Nifty below 8,250 levels
India Infoline

Sensex ends lower; healthcare, auto fall

Indian equities settled lower on Wednesday amid global sell-off. At the close, the benchmark 30-share index, BSE Sensex dropped 71.31 points or 0.27% at 26,710.13. Meanwhile, the broad based NSE Nifty fell by 37.80 or 0.47% at 8,029.80. The ... MyIris, 5 days ago
Sensex surges 100 points...Nifty above 8,250 levels India Infoline, 18 hours ago
Nifty below 8,250 levels India Infoline, 20 hours ago

13 images for bse healthcare, 5 days ago, 2 weeks ago
New Indian Express, 1 month ago, 1 month ago
New Indian Express, 1 month ago
Financial Express, 2 months ago
India Infoline, 1 month ago
India Infoline, 2 months ago
Sify, 2 months ago, 2 months ago

Elder Health Care's independent director B. L. Gupta resigns

Elder Health Care Ltd has informed BSE that Mr. B. L. Gupta who is an Independent Director of the Company has resigned from the Board of Directors as well as from the Member Audit Committee from December 12, 2014. Further, Mr. B. L. Guptas ...
 Moneycontrol.com6 days ago Cadila Healthcare Ltd clarifies on recall of benzonatate capsules  Equity Bulls4 days ago Govt caps prices of 52 more 'essential' drugs  Business Standard India1 week ago Apurva S Diwanji resigns as Director of Cadila Healthcare Ltd  Equity Bulls2 weeks ago
Money Control

GSK Consumer elevates marketing head Jayant Singh to regional position

Related to : GlaxoSmithkline Consumer Healthcare Ltd GlaxoSmithkline Consumer Healthcare Ltd BSE 15 Dec 14 | 12:00 AM 5724.75 -32 (-0.56%) NSE 15 Dec 14 | 12:00 AM 5735.60 -22.8 (-0.4%) GlaxoSmithKline Consumer (GSK) Healthcare ...
 Business Standard India1 week ago Cadila Healthcare rises on launching world's first bio-similar of Adalimumab  Arihant Capital1 week ago Cadila Healthcare hits record high after strong Q2 earnings  Business Standard1 month ago GSK Consumer Healthcare edges up after decent quarterly earnings  Business Standard1 month ago

Time right to add pharma as global currencies shake

MUMBAI: The BSE Healthcare Index has been one of the major losers in the month of December. It fell over 3 per cent following weakness in global currencies against the US dollar. Russia's ruble has been badly affected with rise in the US dollar ...
 Economic Times16 hours ago Sun Pharma, Cipla, Ranbaxy slip for second day in a row; EM currency rout may hurt  Economic Times5 days ago
India Infoline

Market range-bound; BSE Small-cap Index flat

Some buying activity is seen in banking, capital goods, healthcare and realty sectors, while FMCG, metal and power sectors are showing weakness At 10:28AM, the S&P BSE Sensex is trading at 26,820 up 68 points, while NSE Nifty is trading at 8,009 up 17 points.
 India Infoline1 month ago Indices trade in a range  India Infoline1 month ago Nifty tanks 120 pts, BSE Mid, Smallcap fall 2-3%; ITC drags  Moneycontrol.com6 days ago Sensex, Nifty up; BSE Mid- & Small-cap gain  India Infoline2 months ago

BSE Healthcare gains for third session as rupee weakens

MUMBAI: Shares of pharmaceuticals companies made gains for a third straight session as the rupee depreciated further against the US dollar. General weakness in global markets also led to investors shifting to the defensives pack. The BSE Healthcare ...
 Economic Times1 week ago

Zydus launches world's first biosimilar of Adalimumab

Cadila Healthcare Ltd has informed BSE regarding a Press Release dated December 09, 2014, titled " ". Zydus Cadila becomes the first company anywhere in the world to launch the biosimilar of Adalimumab the world's largest selling therapy.Source : ...
 Moneycontrol.com1 week ago Zydus Cadila launches world's first biosimilar of Adalimumab  Equity Bulls1 week ago

Cadila Healthcare slips on buzz of recalling bottles of hypertension drug in US

Cadila Healthcare fell 1.26% to Rs 1,566 at 9:29 IST on BSE on reports the company is voluntarily recalling 15,144 bottles of its anti-hypertension drug Amlodipine Besylate tablets in the US market. Meanwhile, the BSE Sensex was down 24.73 ...
 Capital Market1 week ago

Cadila recalls 15,144 bottles of anti-hypertension drug in US

Cadila Healthcare shares on Monday closed at Rs. 1,586 a piece on the BSE, down 1.34% from its previous close. New Delhi: Cadila Healthcare Ltd is voluntarily recalling 15,144 bottles of its anti-hypertension drug Amlodipine Besylate tablets in ...
 Livemint.com2 weeks ago Cadila recalls 15,144 bottles of hypertension drug in US  Business Standard India2 weeks ago Cadila Healthcare recalls 15,144 bottles of hypertension drug in US  Economic Times2 weeks ago
APN News

Sensex Opens Lower By 77 Points On Profit-Booking

MUMBAI: The BSE sensex fell over 77 points in opening trade on Monday on continued profit-booking in IT, banking and healthcare stocks despite firm trends at other Asian markets. The 30-share barometer fell by 77.17 points, or 0.27pct , to ...
 Silicon India2 weeks ago Sensex, Nifty post worst drop in nearly 8 weeks; Infosys down by 5%  IBN Live2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less